Reconstruction and Analysis of lncRNA–miRNA–mRNA ceRNA Network and Drug Repositioning to Identify Potential Biomarkers and Therapeutic Candidates for Colorectal Cancer
Cancer Informatics · 2026-11 · 25
DOI: 10.1177/11769351261503197 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Informatics, online erschienen am 10.11.2026. Verfasst von Sara Nafei Milani und 2 weiteren Autor:innen. Die Arbeit nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Colorectal cancer (CRC) is one of the most prevalent and life-threatening malignancies worldwide. Despite substantial advances in therapeutic strategies, CRC remains a leading cause of cancer-related mortality, largely due to late-stage diagnosis. Molecular-level investigation of disease mechanisms through bioinformatics approaches enables the identification of key biomarkers and regulatory pathways, facilitating early detection as well as the development of targeted and personalized therapies.
Methods
CRC-specific differentially expressed miRNAs were identified using CRC-filtered datasets obtained from the dbDEMC database. Interactions among lncRNAs, miRNAs, and mRNAs were retrieved from the lncACTdb and miRTarBase databases. A competing endogenous RNA (ceRNA) network was constructed by integrating lncRNA–miRNA and miRNA–mRNA interaction networks. A protein-protein interaction (PPI) network was subsequently developed based on the identified target genes and analyzed using the MCODE algorithm to detect significant functional modules. Functional enrichment analysis was performed to explore the biological roles of the identified biomarkers. A drug-gene interaction network was constructed to identify potential therapeutic candidates. Finally, Pearson correlation analysis was performed to evaluate the co-expression relationship between lncRNAs and their corresponding mRNAs, and immunohistochemistry (IHC) data from the Human Protein Atlas (HPA) were utilized to validate differential gene expression.
Results
Network analysis led to the identification of twelve potential biomarkers associated with CRC, including five miRNAs (hsa-miR-142-5p, hsa-miR-424-5p, hsa-miR-98-5p, hsa-miR-139-5p, and hsa-miR-486-5p), four lncRNAs (NEAT1, XIST, LINC00665, and OIP5-AS1), and four protein-coding genes (PTEN, IGF1R, KRAS, and PIK3CA). Drug repositioning analysis identified Erlotinib, Metformin, and Gefitinib as potential therapeutic candidates for CRC treatment.
Conclusion
This study presents a comprehensive bioinformatics framework for the identification of key biomarkers and potential therapeutic agents in CRC. Integration of lncRNA, miRNA, and mRNA interaction networks revealed critical regulatory elements and pathways involved in CRC progression. The proposed candidate biomarkers and drugs offer promising avenues for future research on colorectal cancer and may contribute to the development of targeted therapies and drug repurposing strategies.
Zitieren
APA
Milani, S. N., MotieGhader, H., & Zakeri, N. S. S. (2026). Reconstruction and Analysis of lncRNA–miRNA–mRNA ceRNA Network and Drug Repositioning to Identify Potential Biomarkers and Therapeutic Candidates for Colorectal Cancer. Cancer Informatics, 25. https://doi.org/10.1177/11769351261503197
Vancouver
Milani SN, MotieGhader H, Zakeri NSS. Reconstruction and Analysis of lncRNA–miRNA–mRNA ceRNA Network and Drug Repositioning to Identify Potential Biomarkers and Therapeutic Candidates for Colorectal Cancer. Cancer Informatics. 2026;25. doi:10.1177/11769351261503197
BibTeX
@article{Milani2026,
author = {Milani, Sara Nafei and MotieGhader, Habib and Zakeri, Negar Sadat Soleimani},
title = {Reconstruction and Analysis of lncRNA–miRNA–mRNA ceRNA Network and Drug Repositioning to Identify Potential Biomarkers and Therapeutic Candidates for Colorectal Cancer},
journal = {Cancer Informatics},
year = {2026},
volume = {25},
doi = {10.1177/11769351261503197}
}
EUVIMED